Kamala Harris has declared that she will support cannabis legalisation in the US. What does this mean for the industry?

In this article we explore some new research which outlines the impact of stigma and inequality on medical cannabis patients in the UK.

The recent increase in ketamine use among young people, highlighted in The Guardian by Owen Bowden-Jones, has ignited concerns across the UK. While some experts, including Bowden-Jones, have described ...

The Medicines and Healthcare products Regulatory Agency (MHRA) is set to release comprehensive guidance across up to five different documents, covering key regulatory changes for Cannabis-Based ...

Welcome to August’s analysis of the MedBud traffic data. The most interesting month we have had yet, and a clear sign that the data we analyse provides a real time accurate representation of how the ...

Under the Equality Act 2010, landlords and housing providers are legally obligated to make “reasonable accommodations” for tenants with disabilities, which includes allowing the use of prescribed ...

As European cannabis undertakes its most significant evolution, how do businesses thrive, and avoid the many potential pitfalls? The European cannabis market is undertaking one of its most significant ...

Labour’s recent proposal to ban disposable vapes, citing concerns over youth access and environmental impact, is a significant misstep. While these issues warrant attention, an outright ban ignores ...

Overdose Awareness Day, observed annually on the 31st of August, is a critical event for raising awareness about the growing issue of drug overdoses. This day not only honours those who have ...